196 related articles for article (PubMed ID: 36282521)
1. From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.
Lemaire V; Bassen D; Reed M; Song R; Khalili S; Lien YTK; Huang L; Singh AP; Stamatelos S; Bottino D; Hua F
Clin Pharmacol Ther; 2023 May; 113(5):963-972. PubMed ID: 36282521
[TBL] [Abstract][Full Text] [Related]
2. QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications.
Sové RJ; Jafarnejad M; Zhao C; Wang H; Ma H; Popel AS
CPT Pharmacometrics Syst Pharmacol; 2020 Sep; 9(9):484-497. PubMed ID: 32618119
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm.
Chelliah V; Lazarou G; Bhatnagar S; Gibbs JP; Nijsen M; Ray A; Stoll B; Thompson RA; Gulati A; Soukharev S; Yamada A; Weddell J; Sayama H; Oishi M; Wittemer-Rump S; Patel C; Niederalt C; Burghaus R; Scheerans C; Lippert J; Kabilan S; Kareva I; Belousova N; Rolfe A; Zutshi A; Chenel M; Venezia F; Fouliard S; Oberwittler H; Scholer-Dahirel A; Lelievre H; Bottino D; Collins SC; Nguyen HQ; Wang H; Yoneyama T; Zhu AZX; van der Graaf PH; Kierzek AM
Clin Pharmacol Ther; 2021 Mar; 109(3):605-618. PubMed ID: 32686076
[TBL] [Abstract][Full Text] [Related]
4. Two heads are better than one: current landscape of integrating QSP and machine learning : An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learning.
Zhang T; Androulakis IP; Bonate P; Cheng L; Helikar T; Parikh J; Rackauckas C; Subramanian K; Cho CR;
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):5-18. PubMed ID: 35103884
[TBL] [Abstract][Full Text] [Related]
5. Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure.
Cheng L; Qiu Y; Schmidt BJ; Wei GW
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):39-50. PubMed ID: 34637069
[TBL] [Abstract][Full Text] [Related]
6. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
Aghamiri SS; Amin R; Helikar T
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
[TBL] [Abstract][Full Text] [Related]
7. Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model.
Ruiz-Martinez A; Gong C; Wang H; Sové RJ; Mi H; Kimko H; Popel AS
PLoS Comput Biol; 2022 Jul; 18(7):e1010254. PubMed ID: 35867773
[TBL] [Abstract][Full Text] [Related]
8. Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology.
Arulraj T; Wang H; Ippolito A; Zhang S; Fertig EJ; Popel AS
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38557676
[TBL] [Abstract][Full Text] [Related]
9. Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model.
Uatay A; Gall L; Irons L; Tewari SG; Zhu XS; Gibbs M; Kimko H
J Pharm Sci; 2024 Jan; 113(1):11-21. PubMed ID: 37898164
[TBL] [Abstract][Full Text] [Related]
10. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
Fleisher B; Brown AN; Ait-Oudhia S
Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Systems Pharmacology for Rare Disease Drug Development.
Bai JP; Wang J; Zhang Y; Wang L; Jiang X
J Pharm Sci; 2023 Sep; 112(9):2313-2320. PubMed ID: 37422281
[TBL] [Abstract][Full Text] [Related]
12. Practical QSP application from the preclinical phase to enhance the probability of clinical success: Insights from case studies in oncology.
Oishi M; Sayama H; Toshimoto K; Nakayama T; Nagasaka Y
Drug Metab Pharmacokinet; 2024 Jun; 56():101020. PubMed ID: 38797089
[TBL] [Abstract][Full Text] [Related]
13. Emulation of Quantitative Systems Pharmacology models to accelerate virtual population inference in immuno-oncology.
Pawłowski T; Bokota G; Lazarou G; Kierzek AM; Sroka J
Methods; 2024 Mar; 223():118-126. PubMed ID: 38246229
[TBL] [Abstract][Full Text] [Related]
14. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
Bai JPF; Earp JC; Pillai VC
AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
[TBL] [Abstract][Full Text] [Related]
15. Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application.
Siler SQ
Pharm Res; 2022 Aug; 39(8):1789-1802. PubMed ID: 35610402
[TBL] [Abstract][Full Text] [Related]
16. Applications of Quantitative System Pharmacology Modeling to Model-Informed Drug Development.
Zhu AZX; Rogge M
Methods Mol Biol; 2022; 2486():71-86. PubMed ID: 35437719
[TBL] [Abstract][Full Text] [Related]
17. The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and development.
Joshi A; Ramanujan S; Jin JY
Eur J Pharm Sci; 2023 Mar; 182():106380. PubMed ID: 36638898
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
[TBL] [Abstract][Full Text] [Related]
19. Virtual Populations for Quantitative Systems Pharmacology Models.
Cheng Y; Straube R; Alnaif AE; Huang L; Leil TA; Schmidt BJ
Methods Mol Biol; 2022; 2486():129-179. PubMed ID: 35437722
[TBL] [Abstract][Full Text] [Related]
20. [An introduction to QSP modeling for pharmacologists].
Sayama H; Nagasaka Y; Tabata K
Nihon Yakurigaku Zasshi; 2019; 154(3):143-150. PubMed ID: 31527365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]